IL6 and COVID-19: By addressing the inflammatory and endothelial dysfunction mechanisms in COVID-19 and non-COVID-19 populations, this study highlights the critical role of inflammation and its markers, such as NLR and IL-6, in endothelial health and potential cardiovascular outcomes.